Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Zura Bio ( (ZURA) ) is now available.
Zura Bio Limited, a clinical-stage immunology company, is set to present at the Piper Sandler 36th Annual Healthcare Conference, showcasing their innovative dual-pathway antibodies for autoimmune and inflammatory diseases. The company is focusing on developing therapeutic indications for three assets, aiming to prove their efficacy and safety in diseases like systemic sclerosis. Investors can catch a live webcast of the event, with a replay available on their website.
See more data about ZURA stock on TipRanks’ Stock Analysis page.